![NICE logo](/sites/default/files/styles/square_card_l/public/media/images/media-2515.jpg.webp?itok=fsPZhxtT)
Brentuximab vedotin
Brentuximab vedotin is to be available on the NHS for first-line treatment of anaplastic large cell lymphoma.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Brentuximab vedotin is to be available on the NHS for first-line treatment of anaplastic large cell lymphoma.
Selinexor shows early potential for people with relapsed or refractory DLBCL who have had at least two previous courses of treatment.
How strong is the evidence that Roundup® contributes to the development of non-Hodgkin lymphoma?
We have united with 24 other cancer charities to develop a 12-point plan for restoring cancer services.
The American Society of Clinical Oncology (ASCO) held a virtual conference at the end of May.
Acalabrutinib shows potential as a chemotherapy-free treatment option for people with CLL who have not been treated before.
Help us safeguard our front-line services by donating to our emergency appeal.
It's #CarersWeek and we're pledging our support for unpaid carers.
There is no better time than now to say a HUGE thank you!
What makes lymphoma a type of blood cancer?